PT942751E - Composicoes para o tratamento de neuropatias perifericas contendo antiodepressivos e/ou inibidores da monoamino-oxidase e/ou vitamina b12 e/ou precursores ou indutores de neurotransmissores - Google Patents
Composicoes para o tratamento de neuropatias perifericas contendo antiodepressivos e/ou inibidores da monoamino-oxidase e/ou vitamina b12 e/ou precursores ou indutores de neurotransmissoresInfo
- Publication number
- PT942751E PT942751E PT97930634T PT97930634T PT942751E PT 942751 E PT942751 E PT 942751E PT 97930634 T PT97930634 T PT 97930634T PT 97930634 T PT97930634 T PT 97930634T PT 942751 E PT942751 E PT 942751E
- Authority
- PT
- Portugal
- Prior art keywords
- vitamin
- compositions
- treatment
- antiodepressive
- monoamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9614121.3A GB9614121D0 (en) | 1996-07-05 | 1996-07-05 | Combined medicament |
GBGB9616019.7A GB9616019D0 (en) | 1996-07-05 | 1996-07-31 | Combined medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
PT942751E true PT942751E (pt) | 2003-02-28 |
Family
ID=26309637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97930634T PT942751E (pt) | 1996-07-05 | 1997-07-04 | Composicoes para o tratamento de neuropatias perifericas contendo antiodepressivos e/ou inibidores da monoamino-oxidase e/ou vitamina b12 e/ou precursores ou indutores de neurotransmissores |
Country Status (10)
Country | Link |
---|---|
US (1) | US6335323B2 (pt) |
EP (1) | EP0942751B1 (pt) |
AT (1) | ATE224733T1 (pt) |
AU (1) | AU3451797A (pt) |
CA (1) | CA2259010A1 (pt) |
DE (1) | DE69715899T2 (pt) |
DK (1) | DK0942751T3 (pt) |
ES (1) | ES2184111T3 (pt) |
PT (1) | PT942751E (pt) |
WO (1) | WO1998001157A1 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197830B1 (en) | 1995-09-22 | 2001-03-06 | Bruce M. Frome | Method for achieving relief from sympathetically mediated pain |
GB9617990D0 (en) | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
US6211171B1 (en) * | 1998-05-19 | 2001-04-03 | Dalhousie University | Use of antidepressants for local analgesia |
GB9904252D0 (en) * | 1999-02-24 | 1999-04-21 | Worsley Andrew P | Composition for the treatment of pain |
US6575147B2 (en) * | 1999-02-25 | 2003-06-10 | Go-Tec | Internal combustion system adapted for use of a dual fuel composition including acetylene |
GB9906808D0 (en) * | 1999-03-24 | 1999-05-19 | Kilgowan Limited | Formulation for treatment of pain |
US6403657B1 (en) * | 1999-10-04 | 2002-06-11 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity |
US6759437B2 (en) * | 1999-10-04 | 2004-07-06 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
GB2355191A (en) * | 1999-10-12 | 2001-04-18 | Laxdale Ltd | Combination formulations for fatigue, head injury and strokes |
GB0216027D0 (en) | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
EP1490073A4 (en) * | 2002-03-21 | 2006-02-01 | Martin C Hinz | SEGMENT OPTIMIZATION TECHNOLOGY FOR THE SEROTONIN AND CATECHOLAMINE SYSTEM |
US20040229285A1 (en) * | 2003-02-21 | 2004-11-18 | Hinz Martin C. | Serotonin and catecholamine system segment optimization technology |
US20070293571A1 (en) * | 2006-06-08 | 2007-12-20 | Hinz Martin C | Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes |
US20090311795A1 (en) * | 2002-03-21 | 2009-12-17 | Hinz Martin C | Bilateral control of functions traditionally regulated by only serotonin or only dopamine |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
JP4638685B2 (ja) * | 2003-06-10 | 2011-02-23 | ハイデルベルガー ドルツクマシーネン アクチエンゲゼルシヤフト | オフセット印刷機による印刷の際に湿し水を調量する方法 |
GB0313630D0 (en) * | 2003-06-12 | 2003-07-16 | Wwk Trust The | Compositions for the enhanced treatment of depression |
US20090306050A1 (en) * | 2006-02-03 | 2009-12-10 | Timothy Dinan | Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
SI2091948T1 (sl) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novi inhibitorji glutaminil ciklaze |
ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
ES2548913T3 (es) | 2009-09-11 | 2015-10-21 | Probiodrug Ag | Derivados heterocíclicos como inhibidores de glutaminil ciclasa |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤 |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
GB2544630A (en) * | 2015-11-19 | 2017-05-24 | The Wwk Trust | Combinations for the treatment of dementia, and the enhancement of cognitive function |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3981863A (en) * | 1975-02-25 | 1976-09-21 | Micromedic Diagonistics, Inc. | Cyanocobalamin derivatives |
US4431670A (en) | 1980-12-19 | 1984-02-14 | Bernardo Heller | D-Phenylalanine treatment |
US4652559A (en) | 1982-08-16 | 1987-03-24 | The Upjohn Company | 2-(Phenylmethylene)cycloalkyl-azetidines |
EP0784476B1 (en) * | 1994-10-05 | 2002-11-06 | Cari Loder | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and optionally a vitamin b 12 compound |
-
1997
- 1997-07-04 CA CA002259010A patent/CA2259010A1/en not_active Abandoned
- 1997-07-04 DK DK97930634T patent/DK0942751T3/da active
- 1997-07-04 AT AT97930634T patent/ATE224733T1/de not_active IP Right Cessation
- 1997-07-04 PT PT97930634T patent/PT942751E/pt unknown
- 1997-07-04 DE DE69715899T patent/DE69715899T2/de not_active Expired - Fee Related
- 1997-07-04 ES ES97930634T patent/ES2184111T3/es not_active Expired - Lifetime
- 1997-07-04 WO PCT/GB1997/001822 patent/WO1998001157A1/en active IP Right Grant
- 1997-07-04 EP EP97930634A patent/EP0942751B1/en not_active Expired - Lifetime
- 1997-07-04 US US09/214,314 patent/US6335323B2/en not_active Expired - Fee Related
- 1997-07-04 AU AU34517/97A patent/AU3451797A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998001157A1 (en) | 1998-01-15 |
DE69715899D1 (de) | 2002-10-31 |
EP0942751A1 (en) | 1999-09-22 |
EP0942751B1 (en) | 2002-09-25 |
DE69715899T2 (de) | 2003-05-28 |
AU3451797A (en) | 1998-02-02 |
US6335323B2 (en) | 2002-01-01 |
ES2184111T3 (es) | 2003-04-01 |
ATE224733T1 (de) | 2002-10-15 |
CA2259010A1 (en) | 1998-01-15 |
DK0942751T3 (da) | 2002-12-02 |
US20010008884A1 (en) | 2001-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT942751E (pt) | Composicoes para o tratamento de neuropatias perifericas contendo antiodepressivos e/ou inibidores da monoamino-oxidase e/ou vitamina b12 e/ou precursores ou indutores de neurotransmissores | |
AU2001231763A1 (en) | Dosing regimen | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
ATE307119T1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
ATE359773T1 (de) | Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren | |
MX9308053A (es) | COMBINACION DE UN INHIBIDOR DE LA BIOSINTESIS DE COLESTEROL Y UN INHIBIDOR DE ABSORCION DE COLESTEROL DE ß-LACTAMA. | |
DE69827777D1 (de) | Zusammensetzungen mit verzögerter Wirkstoffabgabe zur Behandlung der Hyperlipidämie | |
ATE227124T1 (de) | Behandlung von multipler sklerose (ms) und anderen demyelinisationserkrankungen unter verwendung von lofepramin in kombination mit l- phenylalamin, tyrosin oder tryptophan und evtl. einer vitamin b12-verbindung | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
NO996578L (no) | Urokinase-inhibitorer | |
WO2000040235A3 (en) | Treatment of asthma with mek inhibitors | |
ATE234282T1 (de) | Polymorphe verbindungen | |
LV12687B (lv) | Aterosklerozes arstesanas panemiens izmantojot ap2 inhibitoru un to saturosas kombinacijas | |
DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
DK0876158T3 (da) | Ny medicinsk anvendelse af en ACE-inhibitor til behandling af mavesurhedssymptomer | |
HUP9801022A2 (hu) | Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására | |
EA199901043A1 (ru) | ИНГИБИТОРЫ ФАРНЕЗИЛТРАНСФЕРАЗЫ В КОМБИНАЦИИ С ИНГИБИТОРАМИ HMG-CoA-РЕДУКТАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА | |
DK0966283T3 (da) | Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller | |
SE9804126D0 (sv) | New pharmaceutical composition | |
DE69526584D1 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
DK0674521T3 (da) | Fremgangsmåde til behandling af kronisk prostatitis med 17beta-N-tertbutylcarbamoyl-4-aza-5a-andost-1-en-3-on | |
EE9700350A (et) | COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod | |
BR0012502A (pt) | Inibidores da expressão do gene para interleucina 5 | |
DE602004016841D1 (de) | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen | |
NO20013717L (no) | Fremgangsmåte for behandling av hodepine |